Abstract
We describe 84 clinical isolates of Prevotella timonensis recovered between January 2007 and November 2016 at the University Hospital of Montpellier. They were recovered from a variety of clinical samples, mostly of genital and wound origins. All isolates were isolated from a mixed aerobic and anaerobic microbiota. Antimicrobial susceptibility testing of 50 isolates showed 56% of beta-lactamase production and 40% of resistance to clindamycin. One strain was resistant to metronidazole.
Keywords:
Anaerobic bacteria; Antimicrobial resistance; Clinical relevance; France; Prevotella timonensis.
Copyright © 2018 Elsevier Ltd. All rights reserved.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / pharmacology*
-
Bacteria, Anaerobic / classification
-
Bacteria, Anaerobic / drug effects
-
Bacteria, Anaerobic / isolation & purification
-
Bacteroidaceae Infections / diagnosis*
-
Bacteroidaceae Infections / microbiology*
-
Child
-
Child, Preschool
-
Cross Infection*
-
Drug Resistance, Bacterial / drug effects
-
Female
-
France
-
Hospitals, University*
-
Humans
-
Infant
-
Infant, Newborn
-
Male
-
Metronidazole / pharmacology
-
Microbial Sensitivity Tests*
-
Middle Aged
-
Prevotella / classification
-
Prevotella / drug effects*
-
Prevotella / genetics
-
Prevotella / isolation & purification
-
RNA, Ribosomal, 16S / genetics
-
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
-
Young Adult
Substances
-
Anti-Bacterial Agents
-
RNA, Ribosomal, 16S
-
Metronidazole